210
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Phosphorylation of p66shc mediates 6-hydroxydopamine cytotoxicity

, , , , , & show all
Pages 342-350 | Received 24 Aug 2010, Published online: 03 Nov 2010

References

  • Lang A, Lozano A. Parkinson's disease. First of two parts. N Engl J Med 1998;339:1044–1053.
  • Jenner P, Olanow C. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 1996;47(Suppl 3):161–170.
  • Sherer T, Betarbet R, Greenamyre J. Pathogenesis of Parkinson's disease. Curr Opin Investig Drugs 2001;2:657–662.
  • Lotharius J, Brundin P. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat Rev Neurosci 2002;3:932–942.
  • Jenner P. Oxidative mechanisms in nigral cell death in Parkinson's disease. Mov Disord 1998;13(Suppl 1):24–34.
  • de Rijk M, Breteler M, den Breeijen J, Launer L, Grobbee D, van der Meché F, Hofman A. Dietary antioxidants and Parkinson disease. The Rotterdam Study. Arch Neurol 1997;54:762–765.
  • Blum D, Torch S, Lambeng N, Nissou M, Benabid A, Sadoul R, Verna J. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 2001;65: 135–172.
  • Saito Y, Nishio K, Ogawa Y, Kinumi T, Yoshida Y, Masuo Y, Niki E. Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: involvement of hydrogen peroxide-dependent and -independent action. Free Radic Biol Med 2007;42:675–685.
  • Tian L, Wang X, Sun Y, Li C, Xing Y, Zhao H, Duan M, Zhou Z, Wang S. Salvianolic acid B, an antioxidant from Salvia miltiorrhiza, prevents 6-hydroxydopamine induced apoptosis in SH-SY5Y cells. Int J Biochem Cell Biol 2008;40:409–422.
  • Akazawa Y, Saito Y, Nishio K, Horie M, Kinumi T, Masuo Y, Yoshida Y, Ashida H, Niki E. Proteomic characterization of the striatum and midbrain treated with 6-hydroxydopamine: alteration of 58-kDa glucose-regulated protein and C/EBP homologous protein. Free Radic Res 2010;44:410–421.
  • Cohen G, Heikkila R. The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J Biol Chem 1974; 249:2447–2452.
  • Izumi Y, Sawada H, Sakka N, Yamamoto N, Kume T, Katsuki H, Shimohama S, Akaike A. p-Quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly. J Neurosci Res 2005;79:849–860.
  • Pelicci G, Lanfrancone L, Grignani F, McGlade J, Cavallo F, Forni G, Nicoletti I, Pawson T, Pelicci P. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 1992;70:93–104.
  • Rozakis-Adcock M, McGlade J, Mbamalu G, Pelicci G, Daly R, Li W, Batzer A, Thomas S, Brugge J, Pelicci P. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 1992;360:689–692.
  • Cutler R, Liu L, Damen J, Krystal G. Multiple cytokines induce the tyrosine phosphorylation of Shc and its association with Grb2 in hemopoietic cells. J Biol Chem 1993;268: 21463–21465.
  • Ruff-Jamison S, McGlade J, Pawson T, Chen K, Cohen S. Epidermal growth factor stimulates the tyrosine phosphorylation of SHC in the mouse. J Biol Chem 1993;268: 7610–7612.
  • Sasaoka T, Ishiki M, Wada T, Hori H, Hirai H, Haruta T, Ishihara H, Kobayashi M. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis. Endocrinology 2001;142:5226–5235.
  • Migliaccio E, Mele S, Salcini A, Pelicci G, Lai K, Superti-Furga G, Pawson T, Di Fiore P, Lanfrancone L, Pelicci P. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. EMBO J 1997;16:706–716.
  • Lai K, Pawson T. The ShcA phosphotyrosine docking protein sensitizes cardiovascular signaling in the mouse embryo. Genes Dev 2000;14:1132–1145.
  • Migliaccio E, Giorgio M, Mele S, Pelicci G, Reboldi P, Pandolfi P, Lanfrancone L, Pelicci P. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999;402:309–313.
  • Le S, Connors T, Maroney A. c-Jun N-terminal kinase specifically phosphorylates p66ShcA at serine 36 in response to ultraviolet irradiation. J Biol Chem 2001;276:48332–48336.
  • Haga S, Terui K, Fukai M, Oikawa Y, Irani K, Furukawa H, Todo S, Ozaki M. Preventing hypoxia/reoxygenation damage to hepatocytes by p66(shc) ablation: up-regulation of anti-oxidant and anti-apoptotic proteins. J Hepatol 2008;48:422–432.
  • Skulachev V. The p66shc protein: a mediator of the programmed death of an organism? IUBMB Life 2000;49:177–180.
  • Migliaccio E, Giorgio M, Pelicci P. Apoptosis and aging: role of p66Shc redox protein. Antioxid Redox Signal 2006;8: 600–608.
  • Morita S, Kojima T, Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 2000;7:1063–1066.
  • Kitamura T, Koshino Y, Shibata F, Oki T, Nakajima H, Nosaka T, Kumagai H. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp Hematol 2003;31:1007–1014.
  • Yang C, Horwitz S. Taxol mediates serine phosphorylation of the 66-kDa Shc isoform. Cancer Res 2000;60:5171–5178.
  • Hu Y, Wang X, Zeng L, Cai D, Sabapathy K, Goff S, Firpo E, Li B. ERK phosphorylates p66shcA on Ser36 and subsequently regulates p27kip1 expression via the Akt-FOXO3a pathway: implication of p27kip1 in cell response to oxidative stress. Mol Biol Cell 2005;16:3705–3718.
  • Smith W, Norton D, Gorospe M, Jiang H, Nemoto S, Holbrook N, Finkel T, Kusiak J. Phosphorylation of p66Shc and forkhead proteins mediates Abeta toxicity. J Cell Biol 2005; 169:331–339.
  • Pinton P, Rimessi A, Marchi S, Orsini F, Migliaccio E, Giorgio M, Contursi C, Minucci S, Mantovani F, Wieckowski MR, Del Sal G, Pelicci PG, Rizzuto R. Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science 2007;315:659–663.
  • Gonindard C, Bergonzi C, Denier C, Sergheraert C, Klaebe A, Chavant L, Hollande E. Synthetic hispidin, a PKC inhibitor, is more cytotoxic toward cancer cells than normal cells in vitro. Cell Biol Toxicol 1997;13:141–153.
  • Trinei M, Giorgio M, Cicalese A, Barozzi S, Ventura A, Migliaccio E, Milia E, Padura IM, Raker VA, Maccarana M, Petronilli V, Minucci S, Bernardi P, Lanfrancone L, Pelicci PG. A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. Oncogene 2002;21:3872–3878.
  • Kasuno K, Naqvi A, Dericco J, Yamamori T, Santhanam L, Mattagajasingh I, Yang S, Meyskens F, Bosserhoff A, Irani K. Antagonism of p66shc by melanoma inhibitory activity. Cell Death Differ 2007;14:1414–1421.
  • Graiani G, Lagrasta C, Migliaccio E, Spillmann F, Meloni M, Madeddu P, Quaini F, Padura IM, Lanfrancone L, Pelicci P, Emanueli C. Genetic deletion of the p66Shc adaptor protein protects from angiotensin II-induced myocardial damage. Hypertension 2005;46:433–440.
  • Malhotra A, Vashistha H, Yadav V, Dube M, Kalra S, Abdellatif M, Meggs L. Inhibition of p66ShcA redox activity in cardiac muscle cells attenuates hyperglycemia-induced oxidative stress and apoptosis. Am J Physiol Heart Circ Physiol 2009;296:380–388.
  • Zaccagnini G, Martelli F, Fasanaro P, Magenta A, Gaetano C, Di Carlo A, Biglioli P, Giorgio M, Martin-Padura I, Pelicci PG, Capogrossi MC. p66ShcA modulates tissue response to hindlimb ischemia. Circulation 2004;109:2917–2923.
  • Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, Pelliccia G, Luzi L, Minucci S, Marcaccio M, Pinton P, Rizzuto R, Bernardi P, Paolucci F, Pelicci PG. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005;122:221–233.
  • Orsini F, Migliaccio E, Moroni M, Contursi C, Raker VA, Piccini D, Martin-Padura I, Pelliccia G, Trinei M, Bono M, Puri C, Tacchetti C, Ferrini M, Mannucci R, Nicoletti I, Lanfrancone L, Giorgio M, Pelicci PG. The life span determinant p66Shc localizes to mitochondria where it associates with mitochondrial heat shock protein 70 and regulates trans-membrane potential. J Biol Chem 2004;279:25689–25695.
  • Tirmenstein M, Hu C, Scicchitano M, Narayanan P, McFarland D, Thomas H, Schwartz L. Effects of 6-hydroxydopamine on mitochondrial function and glutathione status in SH-SY5Y human neuroblastoma cells. Toxicol In Vitro 2005;19:471–479.
  • Arany I, Faisal A, Nagamine Y, Safirstein R. p66shc inhibits pro-survival epidermal growth factor receptor/ERK signaling during severe oxidative stress in mouse renal proximal tubule cells. J Biol Chem 2008;283:6110–6117.
  • de Keizer P, Burgering B, Dansen T. FOXO as a sensor, mediator and regulator of redox signaling. Antioxid Redox Signal 2010; in press.
  • Nemoto S, Finkel T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 2002;295:2450–2452.
  • Berry A, Greco A, Giorgio M, Pelicci P, de Kloet R, Alleva E, Minghetti L, Cirulli F. Deletion of the lifespan determinant p66(Shc) improves performance in a spatial memory task, decreases levels of oxidative stress markers in the hippocampus and increases levels of the neurotrophin BDNF in adult mice. Exp Gerontol 2008;43:200–208.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.